SCNI (Scinai Immunotherapeutics) Cyclically Adjusted Book per Share: $326.06 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SCNI Scinai Immunotherapeutics Ltd SCNI
20 GF Score
Price $1.65
! 2 Warning Signs
View Full Analysis

What is Scinai Immunotherapeutics Cyclically Adjusted Book per Share?

Scinai Immunotherapeutics SCNI -2.34% 20 Cyclically Adjusted Book per Share is $326.06 as of Jun. 2026. GuruFocus rates SCNI with a GF Score™ of 20/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Scinai Immunotherapeutics's adjusted book value per share for the three months ended in Jun. 2026 was $10.711. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $326.06 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-09-11), Scinai Immunotherapeutics's current stock price is $1.65. Scinai Immunotherapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $326.06. Scinai Immunotherapeutics's Cyclically Adjusted PB Ratio of today is 0.01.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Scinai Immunotherapeutics was 0.05. The lowest was 0.01. And the median was 0.02.


Scinai Immunotherapeutics  (NAS:SCNI) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Scinai Immunotherapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.65/326.06
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Scinai Immunotherapeutics was 0.05. The lowest was 0.01. And the median was 0.02.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Scinai Immunotherapeutics Cyclically Adjusted Book per Share Related Terms


Scinai Immunotherapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Scinai Immunotherapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scinai Immunotherapeutics Cyclically Adjusted Book per Share Chart

Scinai Immunotherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 861.54 737.51 515.31

Scinai Immunotherapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 620.35 515.31 423.01 326.06

SCNI vs BBLG, PTIX, ATXI: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Scinai Immunotherapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scinai Immunotherapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scinai Immunotherapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Scinai Immunotherapeutics's Cyclically Adjusted PB Ratio falls into.


SCNI
20GF Score
Scinai Immunotherapeutics Ltd SCNI
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scinai Immunotherapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scinai Immunotherapeutics's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=10.711/333.9520*333.9520
=10.711

Current CPI (Jun. 2026) = 333.9520.

Scinai Immunotherapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201606 2,587.333 241.018 3,584.981
201609 2,469.333 241.428 3,415.671
201612 2,219.667 241.432 3,070.273
201703 2,704.000 243.801 3,703.866
201706 1,504.500 244.955 2,051.115
201709 2,778.429 246.819 3,759.281
201712 2,312.143 246.524 3,132.128
201803 1,713.857 249.554 2,293.475
201806 652.571 251.989 864.829
201809 573.857 252.439 759.156
201812 -1,184.000 251.233 -1,573.835
201903 -1,204.571 254.202 -1,582.477
201906 -2,898.571 256.143 -3,779.075
201909 -586.600 256.759 -762.958
201912 -1,878.600 256.974 -2,441.345
202003 -1,716.900 258.115 -2,221.344
202006 -1,496.917 257.797 -1,939.117
202009 -44.500 260.280 -57.096
202012 -378.250 260.474 -484.952
202103 445.000 264.877 561.048
202106 249.786 271.696 307.022
202109 92.857 274.310 113.046
202112 54.556 278.802 65.348
202203 267.526 287.504 310.746
202206 67.737 296.311 76.342
202209 138.211 296.808 155.507
202212 -70.400 296.797 -79.213
202303 -145.758 301.836 -161.267
202306 -197.556 305.109 -216.232
202309 -61.182 307.789 -66.383
202312 -99.326 306.746 -108.135
202403 -94.741 312.332 -101.299
202406 -86.714 314.175 -92.173
202409 51.482 315.301 54.527
202412 51.176 315.605 54.151
202503 0.000 319.799 0.000
202506 14.775 322.561 15.297
202512 7.135 324.054 7.353
202603 17.328 330.213 17.524
202606 10.711 333.952 10.711

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $326.06 mean?
Scinai Immunotherapeutics (SCNI) has a Cyclically Adjusted Book per Share of $326.06 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Scinai Immunotherapeutics and its competitors.
Is Scinai Immunotherapeutics' Cyclically Adjusted Book per Share too high?
Scinai Immunotherapeutics' current Cyclically Adjusted Book per Share is $326.06. Overall, Scinai Immunotherapeutics has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Scinai Immunotherapeutics' Cyclically Adjusted Book per Share compare to BBLG and PTIX?
Scinai Immunotherapeutics' Cyclically Adjusted Book per Share of $326.06 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Scinai Immunotherapeutics and its competitors. Scinai Immunotherapeutics's current Cyclically Adjusted Book per Share is $326.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scinai Immunotherapeutics stock overvalued right now?
Scinai Immunotherapeutics (SCNI) has a current Cyclically Adjusted Book per Share of $326.06. The current Cyclically Adjusted Book per Share is $326.06. Scinai Immunotherapeutics' overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Scinai Immunotherapeutics (SCNI), the current Cyclically Adjusted Book per Share is $326.06 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scinai Immunotherapeutics Business Description

Address Hadassah Ein Kerem Campus, 2nd Floor, Jerusalem BioPark, Jerusalem, ISR
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
20GF Score

Get the complete analysis for SCNI

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.65
Price